Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A23488 | 23737314 | Acta Med Iran | Predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients. | 2013 | Details |
A23494 | 23730487 | Korean J Fam Med | Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older. | 2013 | Details |
A23497 | 23727030 | Clin Chim Acta | Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. | 2013 | Details |
A23508 | 26201775 | Hepatol Int | Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival? | 2012 | Details |
A23509 | 26201774 | Hepatol Int | Nonalcoholic fatty liver disease following liver transplantation. | 2013 | Details |
A23530 | 23703776 | Hepatology | Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. | 2013 | Details |
A23536 | 23702094 | BMC Pediatr | Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial. | 2013 | Details |
A23540 | 23698776 | Int J Mol Sci | Obesity-associated oxidative stress: strategies finalized to improve redox state. | 2013 | Details |
A23545 | 23694813 | Clin Chim Acta | Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia. | 2013 | Details |
A23550 | 23690772 | Int J Endocrinol | Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. | 2013 | Details |
A23551 | 23690766 | Int J Endocrinol | Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis. | 2013 | Details |
A23556 | 23684211 | Rev Assoc Med Bras (1992) | Association between nonalcoholic fatty liver disease and coronary artery disease. | 2013 | Details |
A23567 | 23668723 | Proc Nutr Soc | Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. | 2013 | Details |
A23569 | 23666091 | Nutrients | Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. | 2013 | Details |
A23582 | 23657989 | Intern Emerg Med | Physical activity for the prevention and treatment of metabolic disorders. | 2013 | Details |
A23588 | 23653642 | Int J Endocrinol | Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. | 2013 | Details |
A23594 | 23651847 | Am J Physiol Endocrinol Metab | Exercise training improves cutaneous microvascular function in nonalcoholic fatty liver disease. | 2013 | Details |
A23597 | 23643483 | Toxicol Lett | Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease. | 2013 | Details |
A23598 | 23643404 | Metabolism | Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey. | 2013 | Details |
A23599 | 23642511 | Am J Cardiol | Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease. | 2013 | Details |
A23604 | 23634670 | Diabetes Technol Ther | Obesity and diabetes: newer concepts in imaging. | 2013 | Details |
A23609 | 23627940 | Curr Med Chem | Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus. | 2013 | Details |
A23613 | 23626730 | PLoS One | Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability. | 2013 | Details |
A23615 | 23625798 | Pediatr Obes | Calorie-sweetened beverages and fructose: what have we learned 10 years later. | 2013 | Details |
A23631 | 23612512 | Eur J Clin Nutr | Overweight, obesity and related non-communicable diseases in Asian Indian girls and women. | 2013 | Details |
A23661 | 23588628 | Tunis Med | [Non alcoholic fatty liver disease: a new risk factor for cardiovascular disease?]. | 2013 | Details |
A23678 | 23568965 | J Physiol Pharmacol | Is fatty liver always benign and should not consequently be treated? | 2013 | Details |
A23693 | 23560695 | J Diabetes | Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology. | 2013 | Details |
A23697 | 23557879 | Nutr Metab Cardiovasc Dis | The fatty liver index is associated with increased mortality in subjects referred to coronary angiography. | 2013 | Details |
A23704 | 23553630 | J Biol Chem | Metabolomic profiling reveals a role for caspase-2 in lipoapoptosis. | 2013 | Details |
A23724 | 23534297 | Med Pregl | [Cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease]. | 2013 | Details |
A23728 | 23529597 | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | [Non-alcoholic fatty liver disease in obese children and adolescents]. | 2013 | Details |
A23741 | 23516571 | PLoS One | Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease. | 2013 | Details |
A23758 | 23507799 | Nat Rev Gastroenterol Hepatol | Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. | 2013 | Details |
A23762 | 23504985 | Pediatr Obes | Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents. | 2013 | Details |
A23781 | 23485520 | J Hepatol | The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. | 2013 | Details |
A23784 | 23482703 | World J Gastroenterol | NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. | 2013 | Details |
A23789 | 23480577 | Eur J Clin Invest | Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes. | 2013 | Details |
A23793 | 23478245 | Minerva Gastroenterol Dietol | Management of non-alcoholic fatty liver disease. | 2013 | Details |
A23797 | 23475581 | Curr Diab Rep | Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis. | 2013 | Details |
A23799 | 23472083 | PLoS One | Hepatic methionine homeostasis is conserved in C57BL/6N mice on high-fat diet despite major changes in hepatic one-carbon metabolism. | 2013 | Details |
A23806 | 23458891 | Nat Rev Gastroenterol Hepatol | NAFLD in Asia--as common and important as in the West. | 2013 | Details |
A23820 | 23447513 | Pediatr Obes | Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children. | 2013 | Details |
A23824 | 26201622 | Hepatol Int | Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease. | 2012 | Details |
A23835 | 23439508 | Acta Med Okayama | A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohorts. | 2013 | Details |
A23840 | 23433458 | Adv Pharmacol | Eicosanoids in metabolic syndrome. | 2013 | Details |
A23844 | 23432668 | Curr Pharm Des | Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD. | 2013 | Details |
A23846 | 23431426 | J Obes | Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? | 2013 | Details |
A23852 | 23426822 | J Pediatr Endocrinol Metab | Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease. | 2012 | Details |
A23859 | 23424926 | Rev Prat | [Management of non alcoholic fatty liver diseases in adults]. | 2012 | Details |
A23866 | 23419204 | Atherosclerosis | Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. | 2013 | Details |
A23868 | 23418072 | Obesity (Silver Spring) | A metabolically healthy obese phenotype in hispanic participants in the IRAS family study. | 2013 | Details |
A23874 | 23411507 | Endocr J | High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. | 2013 | Details |
A23877 | 23406705 | Pediatr Exerc Sci | Cardiorespiratory fitness, but not central obesity or C-reactive protein, is related to liver function in obese children. | 2013 | Details |
A23881 | 23405890 | Clin Endocrinol (Oxf) | Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders. | 2013 | Details |
A23886 | 23402636 | J Med Food | Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease. | 2013 | Details |
A23906 | 23394094 | Curr Pharm Des | Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? | 2013 | Details |
A23909 | 23394091 | Curr Pharm Des | Epidemiology and natural history of patients with NAFLD. | 2013 | Details |
A23910 | 23394090 | Curr Pharm Des | Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease. | 2013 | Details |
A23922 | 23387384 | Obes Rev | Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. | 2013 | Details |
A23946 | 23363012 | Ann N Y Acad Sci | Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. | 2013 | Details |
A23948 | 23359475 | Pharmacotherapy | Pharmacologic therapy for nonalcoholic fatty liver disease in adults. | 2013 | Details |
A23968 | 23344895 | Pediatr Cardiol | Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease. | 2013 | Details |
A23971 | 23337953 | Nat Rev Endocrinol | The role of hepatokines in metabolism. | 2013 | Details |
A23979 | 23329465 | Drugs | Nonalcoholic fatty liver disease: current issues and novel treatment approaches. | 2013 | Details |
A23983 | 23328905 | Curr Atheroscler Rep | Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review. | 2013 | Details |
A23989 | 23324907 | Herz | Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis. | 2013 | Details |
A23991 | 23323254 | Clin Mol Hepatol | Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease. | 2012 | Details |
A23994 | 23320150 | J Obes | Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? | 2012 | Details |
A23997 | 23317398 | Curr Pharm Des | Ezetimibe therapy for dyslipidemia: an update. | 2013 | Details |
A24003 | 23312215 | J Diabetes Complications | Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. | 2013 | Details |
A24020 | 23298957 | Curr Opin Lipidol | Perspective: nonalcoholic fatty liver disease and cardiovascular risk. | 2013 | Details |
A24032 | 23293330 | J Clin Endocrinol Metab | Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. | 2013 | Details |
A24034 | 23293232 | Georgian Med News | [Relationship gene polymorphism adipor1 with cardiovascular risk in patients with nonalcoholic fatty liver disease]. | 2012 | Details |
A24037 | 23293196 | Ann Hepatol | Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study. | 2013 | Details |
A24043 | 23286927 | Nutr Clin Pract | Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment. | 2013 | Details |
A24057 | 23272512 | Rev Med Chir Soc Med Nat Iasi | Non-alcoholic fatty liver disease is associated with cardiovascular risk factors of metabolic syndrome. | 2013 | Details |
A24059 | 25702427 | Klin Med (Mosk) | [Proinflammatory cytokine levels depending on the stage of hepatic fibrosis in patients with metabolic syndrome and non-alcoholic fatty liver disease]. | 2013 | Details |
A24101 | 23227839 | Biomark Med | Serum biomarkers in nonalcoholic steatohepatitis: value for assessing drug effects? | 2012 | Details |
A24102 | 23227347 | Int J Hepatol | Posttransplant metabolic syndrome. | 2012 | Details |
A24103 | 23227282 | Methodist Debakey Cardiovasc J | Fatty liver: a link to cardiovascular disease--its natural history, pathogenesis, and treatment. | 2013 | Details |
A24115 | 23215811 | J Gastroenterol Hepatol | Apolipoprotein B/AI ratio is independently associated with non-alcoholic fatty liver disease in nondiabetic subjects. | 2013 | Details |
A24121 | 23211853 | Am J Gastroenterol | Non-alcoholic fatty liver disease and obesity: not all about body mass index. | 2012 | Details |
A24136 | 23190589 | Med Sci Sports Exerc | Cardiorespiratory fitness, waist circumference, and alanine aminotransferase in youth. | 2013 | Details |
A24147 | 23178979 | J Hepatol | Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. | 2012 | Details |
A24153 | 23175136 | Hepatology | Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. | 2013 | Details |
A24161 | 23165995 | Mol Nutr Food Res | miRNAs, polyphenols, and chronic disease. | 2012 | Details |
A24174 | 23148186 | Ther Adv Endocrinol Metab | An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD). | 2011 | Details |
A24186 | 23141876 | Int J Cardiol | Non-alcoholic fatty liver disease and cardiovascular risk. | 2012 | Details |
A24187 | 23141586 | Atherosclerosis | The effect of obesity on the association between liver fat and carotid atherosclerosis in a multi-ethnic cohort. | 2012 | Details |
A24188 | 23140546 | Curr Vasc Pharmacol | The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study. | 2013 | Details |
A24189 | 23139599 | World J Gastroenterol | Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. | 2012 | Details |
A24195 | 23131380 | Complement Ther Med | The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders. | 2012 | Details |
A24209 | 23120807 | Acta Med Croatica | [Relationship between nonalcoholic fatty liver disease markers and renal function in patients with type 1 diabetes]. | 2011 | Details |
A24222 | 23108199 | Curr Opin Endocrinol Diabetes Obes | Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome. | 2012 | Details |
A24226 | 23094755 | J Gastroenterol Hepatol | Nonalcoholic fatty liver disease in Asia: a story of growth. | 2013 | Details |
A24227 | 23092327 | Curr Pharm Des | Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
A24228 | 23091922 | Rev Med Brux | [Non alcoholic fatty liver disease assessment]. | 2012 | Details |
A24231 | 23073871 | Intern Emerg Med | Nonalcoholic fatty liver disease and atherosclerosis. | 2012 | Details |
A24232 | 23073870 | Intern Emerg Med | Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. | 2012 | Details |